Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 480

2.

Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2.

Park KJ, Choi SH, Koh MS, Kim DJ, Yie SW, Lee SY, Hwang SB.

Virus Res. 2001 Apr;74(1-2):89-98.

PMID:
11226577
3.
4.
5.
7.
8.

Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.

Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, Ray RB.

Virology. 2002 Mar 1;294(1):94-105.

9.

Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.

Wajant H, Johannes FJ, Haas E, Siemienski K, Schwenzer R, Schubert G, Weiss T, Grell M, Scheurich P.

Curr Biol. 1998 Jan 15;8(2):113-6.

10.

Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor.

Adam-Klages S, Schwandner R, Adam D, Kreder D, Bernardo K, Krönke M.

J Leukoc Biol. 1998 Jun;63(6):678-82. Review.

PMID:
9620659
11.

Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway.

Natoli G, Costanzo A, Ianni A, Templeton DJ, Woodgett JR, Balsano C, Levrero M.

Science. 1997 Jan 10;275(5297):200-3.

13.

Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).

Wajant H, Haas E, Schwenzer R, Muhlenbeck F, Kreuz S, Schubert G, Grell M, Smith C, Scheurich P.

J Biol Chem. 2000 Aug 11;275(32):24357-66.

14.

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.

Varfolomeev E, Maecker H, Sharp D, Lawrence D, Renz M, Vucic D, Ashkenazi A.

J Biol Chem. 2005 Dec 9;280(49):40599-608. Epub 2005 Oct 15.

15.

Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.

Leo E, Welsh K, Matsuzawa S, Zapata JM, Kitada S, Mitchell RS, Ely KR, Reed JC.

J Biol Chem. 1999 Aug 6;274(32):22414-22.

16.

A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.

Adriaenssens E, Mougel A, Goormachtigh G, Loing E, Fafeur V, Auriault C, Coll J.

Oncogene. 2004 Apr 8;23(15):2681-93. Erratum in: Oncogene. 2004 Oct 21;23(49):8184.

PMID:
14767477
17.

Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction.

Krippner-Heidenreich A, Tübing F, Bryde S, Willi S, Zimmermann G, Scheurich P.

J Biol Chem. 2002 Nov 15;277(46):44155-63. Epub 2002 Sep 4.

18.

Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.

Reinhard C, Shamoon B, Shyamala V, Williams LT.

EMBO J. 1997 Mar 3;16(5):1080-92.

19.

Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses.

Ermolaeva MA, Michallet MC, Papadopoulou N, Utermöhlen O, Kranidioti K, Kollias G, Tschopp J, Pasparakis M.

Nat Immunol. 2008 Sep;9(9):1037-46. doi: 10.1038/ni.1638. Epub 2008 Jul 20.

PMID:
18641654

Supplemental Content

Support Center